The level of severity or urgency of an RSM’s medical condition as related to the need for certain care or treatment.

A disposition finding by a PEB for an RSM who has one or more Service unfitting conditions that were incurred in the line of duty and that have a combined rating of 30 percent or higher, and who is considered not stable as a result.

A system of support and advocacy to guide and assist the RSM and family or designated caregiver through treatment, rehabilitation, return to duty, or military retirement and transition into the civilian community.  Each Military Department has a unique wounded warrior program that addresses its Service members’ needs.

An individual assigned by the VA to serve as the ultimate point of contact for an RSM and family or designated caregiver to ensure the RSM medical and non-medical needs are met.

The breach response provisions in the DoD Privacy Program issuances and related breach response guidance from the Office of Management and Budget and DHS.

As used in this Instruction, an organized program of healthcare preventive or therapeutic treatment, or preparations for such treatment, designed to meet the actual, anticipated, or potential needs of a group of military personnel in relation to military missions.

A medical product that has not been approved by the FDA for general commercial marketing or that the FDA has determined may not be used for its intended purpose without an Emergency Use Authorization or under rules applicable to investigational new drugs or investigational devices.

A drug or biological product subject to the FDA regulations at Part 312 of Title 21, Code of Federal Regulations, Parts 50, 56, 312, Subpart I of Part 314, Subpart G  of Part 601, as amended, including: A drug not approved or a biological product not licensed by the FDA and a drug unapproved for its applied use.

An authorization from the FDA under section 564 of Reference (d) with respect to an unapproved product that allows, based on a declaration of emergency by the Secretary of Health and Human Services, the product to be introduced into interstate commerce for use or for the intended use, subject to terms and conditions established by the FDA.  An EUA fo...

 A drug, including a biological product, or a medical device.

As provided in section 1107 of Title 10, United States Code, an FDA-approved drug or biological product administered for a use not described in the approved labeling of the drug or biological product (referred to in subsection (g)(2)) and for which requirements of use authorization (referred to in subsection (d)(4)) and prior informed consent (referred to...

As used in this Instruction, a military operation or specific military mission or function which involves as part of a force health protection program the use of an IND as a medical countermeasure against any chemical, biological, or radiological warfare or other disease or health threat, and the Commissioner of Food and Drugs has determined that prior in...

A world-class health system that supports the military mission by fostering, protecting, sustaining and restoring health.  It also provides the direction, resources, health care providers, and other means necessary for promoting the health of the beneficiary population. These include developing and promoting health awareness issues to educate custome...

The primary healthcare providers whose responsibility is the provision of immediate clinical care and stabilization in preparation for evacuation to the next level of care.  In addition to treating injuries, they treat Service members for common acute minor illnesses.  These elements of medical management prepare patients for return to duty or f...

All measures taken by commanders, supervisors, individual Service members, and the MHS to promote, protect, improve, conserve, and restore the mental and physical well being of Service members across the range of military activities and operations.  These measures enable the fielding of a healthy and fit force, prevention of injuries and illness and ...